GlassScriptPhysician profile
Simon S Cheng
NPI 1396887410
$4,243.76
in general payments reported to CMS, 2019-2025
16 companies · $797 in 2025
The $797 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $309 · 2021: $576 · 2022: $292 · 2023: $852 · 2024: $822 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964 · Entertainment: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,963.76 |
| Entertainment | $507.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,174.07 | 2019-2025 | Myday Contact Lens |
| Optos, INC. | $789.73 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $698.10 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $316.69 | 2024-2025 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $257.22 | 2019-2020 | |
| Lkc Technologies, INC. | $172.38 | 2024 | |
| Abb Con-Cise Optical Group LLC | $163.53 | 2021-2024 | Contact Lens, Spectacle Lenses |
| Maculogix, INC. | $154.03 | 2019 | |
| Optovue, INC. | $115.97 | 2019 | |
| Rxsight INC | $109.86 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Abbvie INC. | $107.78 | 2023 | Alphagan P, Lumigan, Vuity |
| Allergan, INC. | $48.90 | 2022 | |
| Glaukos Corporation | $42.20 | 2021 | |
| Sight Sciences, INC. | $35.78 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $30.50 | 2025 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $27.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.